Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan

Vaccine

Volumn 28, Issue 35, 2010, Pages 5664-5668

  Hara, Megumi ^a   Tanaka, Keitaro ^a   Kase, Tetsuo ^b   Maeda, Akiko ^c   Hirota, Yoshio ^c  

^a SAGA UNIVERSITY   (Japan)

^b OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c Osaka Prefecture University   (Japan)

Author keywords

Antibody efficacy; Elderly; Influenza vaccine

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

AGE; AGED; ANTIBODY TITER; ARTICLE; COMORBIDITY; DRUG EFFICACY; FEMALE; FEVER; GENDER; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEASONAL INFLUENZA; VIRUS STRAIN; BLOOD; EVALUATION STUDY; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INFLUENZA, HUMAN; PROSPECTIVE STUDY; RISK; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; JAPAN; LOGISTIC MODELS; MALE; ODDS RATIO; PROSPECTIVE STUDIES;

EID: 77955089925     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.061     Document Type: Article

References (21)

1. Fukuda K., Levandowski R.A., Bridges C.B., Cox N.J. Inactivated influenza vaccines. Vaccines 2004, 339-370. Saunders, Philadelphia. 4th ed. S.A. Plotkin, W.A. Orenstein (Eds.).
2. The macro-epidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005, 23(44):5133-5143.
3. Nichol K.L. Efficacy and effectiveness of influenza vaccination. Vaccine 2008, 26(Suppl. 4):D17-D22.
4. FDA Guidance for industry: clinical data needed to support the licensure of pandemic influenza. Vaccines 2007.
5. Longini I.M., Koopman J.S., Haber M., Cotsonis G.A. Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. Am J Epidemiol 1988, 128(4):845-859.
6. Hirota Y., Kaji M., Ide S., Kajiwara J., Kataoka K., Goto S., et al. Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. Vaccine 1997, 15(9):962-967.
7. Hara M., Tanaka K., Hirota Y. Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status. Vaccine 2005, 23(12):1457-1463.
8. National Institute of Health J Experimental Virology 1973, Maruzen, Tokyo, pp. 217-225.
9. Infectious Agents Surveillance Report: Influenza 2002/03 season. Top Month 2003, 24(11):281-282.
10. SAS SAS/STAT User's Guide, Version 8 1999, SAS Institute Inc., Cary, NC.
11. de Jong J.C., Palache A.M., Beyer W.E., Rimmelzwaan G.F., Boon A.C., Osterhaus A.D. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003, 115:63-73.
12. Foster D.A., Talsma A., Furumoto-Dawson A., Ohmit S.E., Margulies J.R., Arden N.H., et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992, 136(3):296-307.
13. Ohmit S.E., Monto A.S. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995, 24(6):1240-1248.
14. Monto A.S., Hornbuckle K., Ohmit S.E. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol 2001, 154(2):155-160.
15. Bernstein E.D., Gardner E.M., Abrutyn E., Gross P., Murasko D.M. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine 1998, 16(18):1722-1731.
16. de Bruijn I.A., Remarque E.J., Jol-van der Zijde C.M., van Tol M.J., Westendorp R.G., Knook D.L. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis 1999, 179(1):31-36.
17. Murasko D.M., Bernstein E.D., Gardner E.M., Gross P., Munk G., Dran S., et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002, 37(2-3):427-439.
18. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58(RR-8):1-52.
19. Ozasa K. The effect of misclassification on evaluating the effectiveness of influenza vaccines. Vaccine 2008, 26(50):6462-6465.
20. Hirota Y., Fukushima W., Fujieda M., Ohfuji S., Maeda A. Essential tools for assessing influenza vaccine efficacy in improperly conducted studies: a Japanese perspective. Vaccine 2008, 26(50):6455-6458.
21. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998, 338(20):1405-1412.